Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-17-010238
Filing Date
2017-10-03
Accepted
2017-10-03 14:01:37
Documents
4

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM S-3 fs32017a1_actiniumpharma.htm S-3/A 47136
2 OPINION OF THE MATT LAW FIRM, PLLC fs32017a1ex5-1_actinium.htm EX-5.1 22319
3 CONSENT OF GBH CPAS, PC fs32017a1ex23-1_actinium.htm EX-23.1 2008
4 GRAPHIC ex5-1_001.jpg GRAPHIC 14286
  Complete submission text file 0001213900-17-010238.txt   92336
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-216748 | Film No.: 171117174
SIC: 2834 Pharmaceutical Preparations